GINS4 may positively modulate the cell cycle process of HCC and potentially trigger the tumorigenesis and progression of HCC in a PI3K/AKT/mTOR dependent manner, which needs to be further experimental verification. Here, GINS4 is linked to hepatocellular carcinoma.